Showing results (551-560 of 1,271) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|January 1, 1989
Oculomotor abnormalities and their clinical correlates in schizophreniaG Thaker, B Kirkpatrick, R W Buchanan, et al.Psychopharmacology Bulletin|June 20, 2017
Combined Antipsychotics and Electroconvulsive Therapy in an Acutely Psychotic Patient with Treatment-resistant SchizophreniaRuth Rayikanti, Iga Lentowicz, Badari Birur, et al.Psychopharmacology Bulletin|April 26, 2021
Impact of the Omics-Based Biomarkers on the Fluvoxamine's Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use DisorderM S Zastrozhin, VYu Skryabin, VYu Smirnov, et al.Psychopharmacology Bulletin|April 26, 2021
Adverse Effects of Recreational and Medical CannabisIvan Urits, Karina Charipova, Kyle Gress, et al.Psychopharmacology Bulletin|June 26, 1998
Changes on the Temperament and Character Inventory after paroxetine treatment in volunteers with generalized anxiety disorderC Allgulander, C R Cloninger, T R Przybeck, et al.Psychopharmacology Bulletin|June 26, 1998
Methodologies and outcomes from the sertraline multicenter flexible-dose trialsM H Rapaport, R M Wolkow, C M ClaryPsychopharmacology Bulletin|June 26, 1998
Interclass drug effects and changes in regional brain glucose metabolismM Cooper, J Metz, H de Wit, et al.Psychopharmacology Bulletin|January 1, 1997
Diagnostic criteria for eating disorders: current concerns and future directionsB T Walsh, C B KahnPsychopharmacology Bulletin|January 1, 1997
Eating behavior and eating disorders: the interface between clinical research and clinical practiceS R Sunday, K A HalmiPsychopharmacology Bulletin|January 1, 1997
Eating disorders and comorbidity: empirical, conceptual, and clinical implicationsS A Wonderlich, J E MitchellPageof 128